Skip to content
Home/Companies/Pharma/ProJect Pharmaceutics
PP

ProJect Pharmaceutics

Pharma·Germany·Active·1yr hold

ProJect Pharmaceutics is a pharma company, headquartered in Germany.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns ProJect Pharmaceutics?

ProJect Pharmaceutics is currently owned by AFINUM Management GmbH through AFINUM IX Buyout (2021) (2021 vintage), since 2025.

Hand-verified · updated 2026-07-03

AFINUM Management GmbH
Investor
AFINUM Management GmbH
AFINUM IX Buyout (2021) · 2021 · Small-Mid Buyout

Key facts

HQGermany
SectorPharma
StatusActive

More from AFINUM IX Buyout (2021)

Other portfolio companies in the same fund.

Fairbanks
Active
SaaSNetherlands· 2026
DPS Engineering
Active
SaaSGermany· 2025
Ergon Informatik
Active
SaaSSwitzerland· 2025
sequrio
Active
SaaSGermany· 2025
MedTech Laser Group
Active
MedTechGermany· 2024
Objektkultur Software
Active
SaaSGermany· 2024

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Delpharm
Active
SocadifFrance
Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
Dec Group
Active
capitonSwitzerland· 2025
Essential Pharma
Active
Penta CapitalUK· 2025
Data refreshed weekly · Sourced from public filings